Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: Globus medical | Mind Blowing Facts

From Sundar Pichai to Vinod Khosla: Meet the 26 Indian-origin leaders in America's most successful immigrants list

The story of immigration in America has long been intertwined with innovation, entrepreneurship and economic growth. In its latest ranking of America's most successful immigrants, Forbes highlighted 250 individuals whose contributions have shaped industries ranging from technology and healthcare to finance, academia and entertainment. Among them are 26 India-born and…

The Times of India

3 MedTech Stocks to Grab Now for a Strong 2025

3 MedTech Stocks to Grab Now for a Strong 2025

This article highlights three MedTech stocks poised for growth in 2025

Evaluating Globus Medical: Insights From 11 Financial Analysts

Evaluating Globus Medical: Insights From 11 Financial Analysts

Globus Medical (NYSE:GMED) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Globus Medical's Return On Invested Capital Insights

Pulled from Benzinga Pro data, Globus Medical (NYSE:GMED) posted Q1 earnings of $38.08 million, an increase from Q4 of 152.11%. Sales dropped to $230.55 million, a 7.79% decrease between quarters.

What 6 Analyst Ratings Have To Say About Globus Medical

Analysts have provided the following ratings for Globus Medical (NYSE:GMED) within the last quarter:

Globus Medical: Q1 Earnings Insights

Globus Medical (NYSE:GMED) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings Globus Medical missed estimated earnings by 10.64%, reporting an EPS of $0.42 versus an estimate of $0.47.

Where Globus Medical Stands With Analysts

Analysts have provided the following ratings for Globus Medical (NYSE:GMED) within the last quarter:

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2022

Expert Ratings For Globus Medical

Expert Ratings For Globus Medical

Within the last quarter, Globus Medical (NYSE:GMED) has observed the following analyst ratings:

Globus Medical's Q4 Earnings Beat Estimates, But FY22 Outlook Lags

Globus Medical's Q4 Earnings Beat Estimates, But FY22 Outlook Lags

Globus Medical Inc's (NYSE: GMED) Q4 sales rea

Globus Medical: Q4 Earnings Insights

Globus Medical: Q4 Earnings Insights

Globus Medical (NYSE:GMED) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Earnings Preview: Globus Medical

Earnings Preview: Globus Medical

Globus Medical (NYSE:GMED) is set to give its latest quarterly earnings report on Thursday, 2022-02-17. Here's what investors need to know before the announcement. Analysts estimate that Globus Medical will report an earnings per share (EPS) of $0.47.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Bank of America

Stanford University

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Economic Growth

Entrepreneurship

Places

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play